November 6, 2014
Nevro, a medical device company focused on the development and commercialization of a high-frequency spinal cord stimulation device for chronic pain, priced its initial public offering today. The company is listed on the NYSE and trades under the symbol NVRO.
Nevro offered 7,000,000 shares of common stock priced at $18 per share, above the announced filing range of $15 to $17 per share. The market capitalization of Nevro at pricing was $466 million.